2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium: Meeting highlights

Authors

  • Anil Kapoor Urologic Cancer Centre for Research and Innovation (UCCRI), McMaster University
  • Tamim Niazi Division of Radiation Oncology, Department of Oncology, McGill University
  • Krista Noonan BC Cancer and University of British Columbia
  • Ricardo A. Rendon Department of Urology, Dalhousie University
  • Nimira Alimohamed Tom Baker Cancer Centre, University of Calgary
  • Wassim Kassouf Department of Surgery, McGill University
  • Alejandro Berlin Cancer Digital Intelligence Program, Princess Margaret Cancer Centre, University Health Network, Toronto
  • William Chu Sunnybrook Health Sciences Centre, University of Toronto
  • Christian Kollmannsberger Division of Medical Oncology, University of British Columbia and BC Cancer
  • Alan I. So Department of Urological Sciences, University of British Columbia

DOI:

https://doi.org/10.5489/cuaj.7875

Keywords:

ASCO-GU, kidney cancer, prostate cancer, bladder cancer

Abstract

The 2022 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium was held in San Francisco and online from February 17–19, 2022. Following the symposium, on February 22, the Canadian Urological Association (CUA) held an online webinar where Canadian experts highlighted key research findings in prostate, bladder, and kidney cancers. In this report, we summarize these exciting advances in GU oncology. The entire webinar can be viewed on the CUA website, and meeting abstracts can be viewed at the ASCO meeting library.

Downloads

Download data is not yet available.

Downloads

Published

2022-03-31

How to Cite

Kapoor, A., Niazi, T. ., Noonan, K. ., Rendon, R. A. ., Alimohamed, N. ., Kassouf, W. ., Berlin, A. ., Chu, W. ., Kollmannsberger, C. ., & So, A. I. . (2022). 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium: Meeting highlights. Canadian Urological Association Journal, 16(4). https://doi.org/10.5489/cuaj.7875

Issue

Vol. 16 No. 4 (2022): CUAJ April

Section

Special Feature

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.